The design, execution, and interpretation of genetic association studies to decipher complex diseases

American Journal of Obstetrics and Gynecology

Volumn 187, Issue 5, 2002, Pages 1299-1312

  Romero, Roberto ^a   Kuivaniemi, Helena ^b   Tromp, Gerard ^b   Olson, Jane M ^c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Complex disorders; Genetic studies; Linkage disequilibrium; Polymorphisms; Single nucleotide polymorphisms

Indexed keywords

ARTICLE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MEDICAL RESEARCH; METHODOLOGY; MULTIVARIATE ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPRODUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0036854210     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.128319     Document Type: Article

References (117)

1. Dizon-Townson DS, Major H, Varner M, Ward K. A promoter mutation that increases transcription of the tumor necrosis factor-α gene is not associated with preterm delivery. Am J Obstet Gynecol 1997;177:810-3.
2. Dizon-Townson DS, Nelson LM, Jang H, Varner MW, Ward K. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis. Am J Obstet Gynecol 1997;176:883-6.
3. Dizon-Townson DS, Meline L, Nelson LM, Varner M, Ward K. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997;177:402-5.
4. 2-Adrenergic receptor genotype and preterm delivery. Am J Obstet Gynecol 2002;187:1294-8.
5. Morgan T, Craven C, Lalouel JM, Ward K. Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua. Am J Obstet Gynecol 1999;180:95-102.
6. Murtha AP, Herbert ANP, Lieff S, Kornman K, Knobelman C, Stephenson K, et al. Preterm delivery and maternal interleukin-1 polymorphisms [abstract]. Am J Obstet Gynecol 2000;182:S12.
7. Roberts AK, Monzon-Bordonaba F, Van Deerlin PG, Holder J, Macones GA, Morgan MA, et al. Association of polymorphism within the promoter of the tumor necrosis factor-α gene with increased risk of preterm premature rupture of the fetal membranes. Am J Obstet Gynecol 1999;180:1297-302.
8. Livingston JC, Barton JR, Park V, Haddad B, Phillips O, Sibai BM. Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am J Obstet Gynecol 2001;185:153-7.
9. De Groot CJ, Bloemenkamp KW, Duvekot EJ, Helmerhorst FM, Bertina RM, Van Der Meer F, et al. Preeclampsia and genetic risk factors for thrombosis: A case-control study. Am J Obstet Gynecol 1999;181:975-80.
10. Wade N. A genomic treasure hunt may be striking gold. New York Times. June 18, 2002; science section.
11. Ginsburg GS, McCarthy JJ. Personalized medicine: Revolutionizing drug discovery and patient care. Trends Biotechnol 2001;19:491-6.
12. Collins FS, Guttmacher AE. Genetics moves into the medical mainstream. JAMA 2001;286:2322-4.
13. Collins FS, Mansoura MK. The Human Genome Project: Revealing the shared inheritance of all humankind. Cancer 2001;91:221-5.
14. Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions: A systematic review. JAMA 2001;286:2270-9.
15. Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, et al. Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma. Int Arch Allergy Immunol 2001;124:183-6.
16. Liggett SB. Pharmacogenetics of beta-1- and beta-2-adrenergic receptors. Pharmacology 2000;61:167-73.
17. Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000;405:847-56.
18. Subramanian G, Adams MD, Venter JC, Broder S. Implications of the human genome for understanding human biology and medicine. JAMA 2001;286:2296-307.
19. McKusick VA. The anatomy of the human genome: A neoVesalian basis for medicine in the 21st century. JAMA 2001;286:2289-95.
20. Elston RC. Linkage and association. Genet Epidemiol 1998;15:565-76.
21. Khoury MJ, Beary TH, Cohen BH. Fundamentals of genetic epidemiology. In: Kelsey J, Marnot M, Stolley P, Vessey M, editors. Monographs in Epidemiology and Biostatistics. Volume 22. New York: Oxford University Press; 1993. p. 3-383.
22. Strachan T, Read AP. Human Molecular Genetics. New York: John Wiley; 1999.
23. Chakravarti A. Population genetics - Making sense out of sequence. Nat Genet 1999;21:56-60.
24. Gibson PS, Muse SV. A Primer of Genome Science. Sunderland (MA): Sinauer Associates; 2002.
25. Hartl DL, Clark AG. Principles of Population Genetics. Sunderland: Sinauer Associates; 1989.
26. Tabor HK, Risch NJ, Myers RM. Opinion: Candidate-gene approaches for studying complex genetic traits. Practical considerations. Nat Rev Genet 2002;3:391-7.
27. Weiss KM, Terwilliger JD. How many diseases does it take to map a gene with SNPs? Nat Genet 2000;26:151-7.
28. Fallin D, Cohen A, Essioux L, Chumakov I, Blumenfeld M, Cohen D, et al. Genetic analysis of case/control data using estimated haplotype frequencies: Application to APOE locus variation and Alzheimer's disease. Genome Res 2001;11:143-51.
29. Rees J. Complex disease and the new clinical sciences. Science 2002;296:698-700.
30. Schork NJ, Fallin D, Thiel B, Xu X, Broeckel U, Jacob HJ, et al. The future of genetic case-control studies. In: Rao D, Province M, editors. Genetic Dissection of Complex Traits. San Diego: Academic Press; 2001. p. 191-212.
31. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001;2:91-9.
32. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-7.
33. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (1DDM). Am J Hum Genet 1993;52:506-16.
34. Terwilliger JD, Goring HH. Gene mapping in the 20th and 21st centuries: Statistical methods, data analysis, and experimental design. Hum Biol 2000;72:63-132.
35. Romero R. The child is the father of the man. Prenat Neonat Med 1996;1:8-11.
36. Romero R, Mazor M, Munoz H, Gomez R, Galasso M, Sherer DM. The preterm labor syndrome. Ann N Y Acad Sci 1994;734:414-29.
37. Goodwin TM. Nausea and vomiting of pregnancy: An obstetric syndrome. Am J Obstet Gynecol 2002;185(Suppl):S184-9.
38. Dahlman I, Eaves IA, Kosoy R, Morrison VA, Heward J, Gough SC, et al. Parameters for reliable results in genetic association studies in common disease. Nat Genet 2002;30:149-50.
39. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001;29:306-9.
40. Pfaff CL, Parra EJ, Bonilla C, Hiester K, McKeigue PM, Kamboh MI, et al. Population structure in admixed populations: Effect of admixture dynamics on the pattern of linkage disequilibrium. Am J Hum Genet 2001;68:198-207.
41. Parra EJ, Marcini A, Akey J, Martinson J, Batzer MA, Cooper R, et al. Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet 1998;63:1839-51.
42. Parra EJ, Kittles RA, Argyropoulos G, Pfaff CL, Hiester K, Bonilla C, et al. Ancestral proportions and admixture dynamics in geographically defined African Americans living in South Carolina. Am J Phys Anthropol 2001;114:18-29.
43. Hon YY, Fessing MY, Pui CH, Relling MV, Krynetski EY, Evans WE. Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Hum Mol Genet 1999;8:371-6.
44. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 2000;97:10483-8.
45. Collins-Schramm HE, Phillips CM, Operario DJ, Lee JS, Weber JL, Hanson RL, et al. Ethnic-difference markers for use in mapping by admixture linkage disequilibrium. Am J Hum Genet 2002;70:737-50.
46. Loos RJ, Beunen G, Fagard R, Derom C, Vlietinck R, Phillips DI. Twin studies and estimates of heritability. Lancet 2001;357:1445.
47. Treloar SA, Macones GA, Mitchell LE, Martin NG. Genetic influences on premature parturition in an Australian twin sample. Twin Res 2000;3:80-2.
48. Vogel F, Motulsky AG. Human Genetics: Problems and Approaches. Heidelberg: Springer-Verlag; 1997.
49. Risch N. Linkage strategies for genetically complex traits, I: Multilocus models. Am J Hum Genet 1990;46:222-8.
50. Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE, et al. Haplotype variation and linkage disequilibrium in 313 human genes. Science 2001;293:489-93.
51. Ott J. Analysis of Human Genetic Linkage. Baltimore: Johns Hopkins University Press; 1999.
52. Ott J, Bhat A. Linkage analysis in heterogeneous and complex traits. Eur Child Adolesc Psychiatry 1999;8(3 Suppl):43-6.
53. Dean FB, Hosono S, Fang L, Wu X, Faruqi AF, Bray-Ward P, et al. Comprehensive human genome amplification using multiple displacement amplification. Proc Natl Acad Sci U S A 2002;99:5261-6.
54. Kuivaniemi H, Yoon S, Shibamura H, Skunca M, Vongpunsawad S, Tromp G. Primer-extension preamplified DNA is a reliable template for genotyping. Clin Chem. 2002;48:1601-3.
55. Griffiths AJE, Miller JH, Suzuki DT, Lewontin RC, Gelbart WM. An Introduction to Genetic Analysis. New York: WH Freeman; 1993.
56. Annas GJ. Reforming informed consent to genetic research. JAMA 2001;286:2326-8.
57. Beskow LM, Burke W, Merz JF, Barr PA, Terry S, Penchaszadeh VB, et al. Informed consent for population-based research involving genetics. JAMA 2001;286:2315-21.
58. Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, et al. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls: Study Group for Pooled-Analysis in Venous Thromboembolism. Thromb Haemost 2001;86:809-16.
59. Rai RS, Regan L, Chitolie A, Donald JG, Cohen H. Placental thrombosis and second trimester miscarriage in association with activated protein C resistance. Br J Obstet Gynaecol 1996;103:842-4.
60. Morgan T, Ward K. New insights into the genetics of preeclampsia. Semin Perinatol 1999;23:14-23.
61. Kupferminc MJ, Eldor A, Steinman N, Many A. Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
62. Dizon-Townson DS, Kinney S, Branch DW, Ward K. The factor V Leiden mutation is not a common cause of recurrent miscarriage. J Reprod Immunol 1997;34:217-23.
63. Arngrimsson R, Purandare S, Connor M, Walker JJ, Bjornsson S, Soubrier F, et al. Angiotensinogen: A candidate gene involved in preeclampsia? Nat Genet 1993;4:114-5.
64. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993;4:59-61.
65. Morgan L, Crawshaw S, Baker PN, Broughton Pipkin F, Kalsheker N. Maternal and fetal angiotensinogen gene allele sharing in pre-eclampsia. Br J Obstet Gynaecol 1999;106:244-51.
66. Suzuki Y, Tanemura M, Murakami I, Suzumori K. Is angiotensinogen gene polymorphism associated with hypertension in pregnancy? Hypertens Pregnancy 1999;18:261-71.
67. Dizon-Townson D, Ward K. The genetics of labor. Clin Obstet Gynecol 1997;40:479-84.
68. Genc M, Gerber S, Nesin M, Witkin S. Polymorphism in the interleukin 1 gene complex and preterm delivery [abstract]. Am J Obstet Gynecol 2001;185:S86.
69. Witkin SS, Gerber S, Ledger WJ. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2002;34:204-9.
70. Hefler LA, Tempfer CB, Gregg AR. Polymorphisms within the interleukin-1 beta gene cluster and preeclampsia. Obstet Gynecol 2001;97:664-8.
71. Saji F, Samejima Y, Kamiura S, Sawai K, Shimoya K, Kimura T. Cytokine production in chorioamnionitis. J Reprod Immunol 2000;47:185-96.
72. Romero R, Manogue KR, Mitchell MD, Wu YK, Oyarzun E, Hobbins JC, et al. Infection and labor, IV: Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 1989;161:336-41.
73. Romero R, Brody DT, Oyarzun E, Mazor M, Wu YK, Hobbins JC, et al. Infection and labor, III: Interleukin-1. A signal for the onset of parturition. Am J Obstet Gynecol 1989;160:1117-23.
74. Romero R, Mazor M, Tartakovsky B. Systemic administration of interleukin-1 induces preterm parturition in mice. Am J Obstet Gynecol 1991;165:969-71.
75. Romero R, Ceska M, Avila C, Mazor M, Behnke E, Lindley I. Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol 1991;165:813-20.
76. Arngrímsson R, Sigurdardóttir S, Frigge ML, Bjarnadóttir RI, Jónsson T, Stefánsson H, et al. A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum Mol Genet 1999;8:1799-805.
77. Ridker PM, Miletich JP. Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women: Implications for venous thromboembolism screening. JAMA 1997;277:1305-7.
78. Fujimoto T, Parry S, Urbanek M, Sammel M, Macones G, Kuivaniemi H, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem 2002;277:6296-302.
79. Ferrand PE, Parry S, Sammel M, Macones GA, Kuivaniemi H, Romero R, et al. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 2002;8:494-501.
80. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: A multicenter study. JAMA 1999;282:561-8.
81. Knight JC, Udalova I, Hill AV, Greenwood BM, Peshu N, Marsh K, et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999;22:145-50.
82. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, et al. A common functional polymorphism (C → A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999;8:1443-9.
83. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-10.
84. Berger P, McConnell JP, Nunn M, Kornman KS, Sorrell J, Stephenson K, et al. C-reactive protein levels are influenced by common IL-1 gene variations. Cytokine 2002;17:171-4.
85. Rai R, Shlebak A, Cohen H, Backos M, Holmes Z, Marriott K, et al. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod 2001;16:961-5.
86. Weller JI, Song JZ, Heyen DW, Lewin HA, Ron M. A new approach to the problem of multiple comparisons in the genetic dissection of complex traits. Genetics 1998;150:1699-706.
87. Province MA. A single, sequential, genome-wide test to identify simultaneously all promising areas in a linkage scan. Genet Epidemiol 2000;19:301-22.
88. Freely associating. Nat Genet 1999;22:1-2.
89. Cooper DN, Nussbaum RL, Krawczak M. Proposed guidelines for papers describing DNA polymorphism-disease associations. Hum Genet 2002;110:207-8.
90. Many A, Schreiber L, Rosner S, Lessing JB, Eldor A, Kupferminc MJ. Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol 2001;98:1041-4.
91. Lockwood CJ. Inherited thrombophilias in pregnant patients: Detection and treatment paradigm. Obstet Gynecol 2002;99:333-41.
92. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002;101:6-14.
93. Grandone E, Margaglione M. Maternal and fetal inherited thrombophilias [letter]. Am J Obstet Gynecol 2002;186:1376.
94. Sibai BM. Maternal and fetal inherited thrombophilias [letter]. Am J Obstet Gynecol 2002;186:1376-7.
95. Rupert JL, Monsalve MV, Devine DV, Hochachka PW. Beta2-adrenergic receptor allele frequencies in the Quechua, a high altitude native population. Ann Hum Genet 2000;64:135-43.
96. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002;4:45-61.
97. Bacanu SA, Devlin B, Roeder K. The power of genomic control. Am J Hum Genet 2000;66:1933-44.
98. Wang X, Zuckerman B, Pearson C, Kaufman G, Chen C, Wang G, et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 2002;287:195-202.
99. Macones G, Parry, S, Marder S, Elkousy M, Ural S, Clothier B, et al. Evidence of a gene-environment interaction in the etiology of spontaneous preterm birth [abstract]. Am J Obstet Gynecol 2001;184:S3.
100. Avent ND; Reid ME. The Rh blood group system: A review. Blood 2000;95:375-87.
101. McCrae KR, Bussel JB, Mannucci PM, Remuzzi G, Cines DB. Platelets: An update on diagnosis and management of thrombocytopenic disorders. Hematology (Am Soc Hematol Educ Program) 2001;282-305.
102. Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-8.
103. Romero R, Dekker G, Kupferminc MJ, Sibai BM. Will heparin prevent adverse pregnancy outcome? J Matern Fetal Med 2002;12:1-7.
104. Dekker CA, de Vries JI, Doelitzsch PM, Huijgens PC, von Blomberg BM, Jakobs C, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995;173:1042-8.
105. Dizon-Townson DS. Preterm labour and delivery: A genetic predisposition. Paediatr Perinat Epidemiol 2001;15(2 Suppl):57-62.
106. Weinberg CR, Wilcox AJ, Lie RT. A log-linear approach to case-parent-triad data: Assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting. Am J Hum Genet 1998;62:969-78.
107. Mitchell LE. Differentiating between fetal and maternal genotypic effects, using the transmission test for linkage disequilibrium. Am J Hum Genet 1997;60:1006-7.
108. Shields DC, Kirke PN, Mills JL, Ramsbottom D, Molloy AM, Burke H, et al. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 1999;64:1045-55.
109. Roberts JM. Pre-eclampsia and cardiovascular disease later in life: Who is at risk? BMJ 2001;323:1217.
110. Sibai BM, el-Nazer A, Gonzalez-Ruiz A. Severe preeclampsiaeclampsia in young primigravid women: Subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986;155:1011-6.
111. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: Population based cohort study. BMJ 2001;323:1213-7.
112. Romero R, Kuivaniemi H, Tromp G. Functional genomics and proteomics in term and preterm parturition. J Clin Endocrinol Metab 2002;87:2431-4.
113. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 1998;279:1200-5.
114. Evans WE, Relling MV. Pharmacogenomics: Translating functional genomics into rational therapeutics. Science 1999;286:487-91.
115. Evans WE, Johnson JA. Pharmacogenomics: The inherited basis for interindividual differences in drug response. Annu Rev Genomics Hum Genet 2001;2:9-39.
116. Ingelman-Sundberg M, Evans WE. Unravelling the functional genomics of the human CYP2D6 gene locus. Pharmacogenetics 2001;11:553-4.
117. Lankas GR, Wise LD, Cartwright ME, Pippert T, Umbenhauer DR. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod Toxicol 1998;12:457-63.